ERIN PERRY: Open Payments
NPI 1093410995 · VERNON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,511 in 68 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $515 · 2025 $1,511
Food & beverage: $1,511
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 21 | $417 |
| AstraZeneca Pharmaceuticals LP | 11 | $244 |
| Verona Pharma, Inc. | 6 | $146 |
| Regeneron Healthcare Solutions, Inc. | 5 | $106 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $98 |
| HARMONY BIOSCIENCES LLC | 2 | $78 |
| Axsome Therapeutics, Inc. | 3 | $77 |
| Amgen Inc. | 2 | $47 |
| INOGEN, INC. | 2 | $46 |
| Avadel CNS Pharmaceuticals, LLC | 2 | $43 |
Products named: NUCALA, Ohtuvayre, DUPIXENT, FASENRA, GLASSIA, AIRSUPRA, TEZSPIRE, TRELEGY ELLIPTA.
Industry payments across CT — which companies pay providers there.
